Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Radiation Injuries 1Precancerous Conditions 1Ovarian Neoplasms 1Neurofibromatosis 1 1Melanoma 1Leukemia, Myeloid, Acute 1Carcinoma, Ovarian Epithelial 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 4Cisplatin 4Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2Donepezil 2Carboplatin 2Bevacizumab 2Amifostine 2sargramostim 1ethanethiol 1Vincristine 1Surgical Procedures, Operative 1Selenomethionine 1Salts 1Rituximab 1Radiation 1Procarbazine 1Oral Hygiene 1Neck Dissection 1Mometasone Furoate 1Methylprednisolone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lovastatin 1Fluorouracil 1Fibroblast Growth Factor 7 1Drug Therapy 1Cytarabine 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Radiation Injuries × Lovastatin × Clear all
NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡